Advertisement
Screener

Foghorn Therapeutics Inc. (FHTX) Beta

Foghorn Therapeutics Inc. (FHTX) Beta

  • Beta · 5-year monthly: Value 2.86; Formula and calculation Saved five-year monthly beta; measures historical sensitivity to the benchmark..

Beta

Overview →

Financial period ending 2026-08-31; current quote 2026-08-31. Amounts retain their stated periods and units.

MetricValueFormula and calculation
Beta · 5-year monthly2.86Saved five-year monthly beta; measures historical sensitivity to the benchmark.

Calculated history

Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.

Period endingBeta
2026-08-312.86

(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.

Similar stocks

Stock NameCountryMarket CapPE Ratio
Eledon Pharmaceuticals, Inc. (ELDN)United States$0.219B-3.23
Whitehawk Therapeutics, Inc. (WHWK)United States$0.221B
Nkarta, Inc. (NKTX)United States$0.205B-1.73
NATURES SUNSHINE PRODUCTS INC (NATR)United States$0.228B20.51
ORAMED PHARMACEUTICALS INC. (ORMP)$0.199B1.13
Keros Therapeutics, Inc. (KROS)United States$0.229B-2.55
Zentalis Pharmaceuticals, Inc. (ZNTL)United States$0.196B-2.48
Cartesian Therapeutics, Inc. (RNAC)United States$0.231B-2.04
SIGA TECHNOLOGIES INC (SIGA)United States$0.234B-93.33
Sionna Therapeutics, Inc. (SION)United States$0.236B-20.37